Prof. Dr. Victor Gault Appointed Section Editor-in-Chief of Section “Endocrinology and Clinical Metabolic Research” in Metabolites

We are pleased to announce the appointment of Prof. Dr. Victor Gault as the new Section Editor-in-Chief of the Section “Endocrinology and Clinical Metabolic Research” in Metabolites (ISSN: 2218-1989).

Prof. Dr. Victor Gault received a BSc (Hons) in Biochemistry from the Queen’s University of Belfast and a PhD in Diabetes and Endocrinology from Ulster University. He is a Professor of Experimental Medicine and Pro-Vice Chancellor and Executive Dean of the Faculty of Life and Health Sciences at Ulster University. His primary interests focus on the function of gut hormones and peptide mimetics in normal physiology, their mechanism of action, and potential role in pathophysiology and in the treatment of diabetes and related disorders. He has published widely, presented his research at numerous national/international conferences, and serves on a range of professional committees and editorial boards. He has also been a recipient of several awards for his research, including the EASD Rising Star Award, and RD Lawrence Lecturer Award at Diabetes UK.

The following is a short Q&A with Prof. Dr. Victor Gault, who shared his vision for the journal with us, as well as his views on the research area.

I have been involved with the journal over several years, and I continue to be impressed by the breadth and depth of its published work, as well as the strong engagement and support from the Editorial Board and wider journal team. The journal’s clear editorial vision and commitment to scholarly excellence are evident. As the Section Editor-in-Chief of “Endocrinology and Clinical Metabolic Research”, I am committed to advancing this mission.

My vision is to further establish Metabolites as a leading journal for high-quality endocrinology and metabolic research. I plan to work closely with the editorial team to promote an internationally engaged community of authors and reviewers by developing targeted Special Issues and organizing scholarly workshops that deepen our understanding of disease mechanisms and emerging therapeutic strategies.

The field of endocrinology and metabolic research is advancing rapidly. Strengthening emphasis on multi-omics integration and precision metabolic medicine will be essential for driving forward the next generation of discoveries and improving patient care.

Open access has become a significant advancement in scholarly publishing, enhancing the visibility and reach of research discoveries. This is especially important in fast-moving fields such as metabolomics, where timely access to new findings accelerates progress.

We wish Prof. Dr. Victor Gault every success in his new position, and we look forward to seeing his contributions to the journal.

Metabolites Editorial Office